CAR- T as well as cell genetics treatments are too pricey

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and innovation transmission may provide cellular genetics therapies at an economical price to people across the planet.